TRIM6-TRIM34 Activators
TRIM6-TRIM34 function by modulating various cellular signaling pathways to enhance its E3 ubiquitin ligase activity. Forskolin acts by directly activating adenylate cyclase, which increases intracellular cAMP levels. This elevation in cAMP can activate protein kinase A (PKA), a kinase known to phosphorylate various substrates within the cell. The phosphorylation events mediated by PKA are crucial as they can lead to the modification of proteins that interact with TRIM6-TRIM34, thereby enhancing its ligase activity. Similarly, 8-Bromo-cAMP, a cell-permeable cAMP analog, mimics the action of cAMP and activates PKA, resulting in the phosphorylation of proteins that are part of the TRIM6-TRIM34 signaling pathways. Isoproterenol and PGE2 also increase cAMP levels, albeit through the activation of beta-adrenergic receptors and PGE2 receptors, respectively, which then triggers a cascade leading to PKA activation and subsequent phosphorylation events that can aid in the activation of TRIM6-TRIM34.
IBMX and Rolipram work by inhibiting phosphodiesterases, enzymes responsible for breaking down cAMP. By preventing cAMP degradation, these inhibitors indirectly contribute to the activation of PKA and the subsequent phosphorylation of substrates that can interact with and activate TRIM6-TRIM34. Specificity in this process is provided by Rolipram, which selectively inhibits PDE4, a particular class of phosphodiesterases. Anisomycin, a protein synthesis inhibitor, activates stress-activated protein kinases, which can lead to the phosphorylation of TRIM6-TRIM34 substrates, while Salubrinal, by inhibiting eIF2α dephosphorylation, can activate stress response pathways that may include TRIM6-TRIM34 activation. Thapsigargin and Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent kinases that phosphorylate proteins associated with TRIM6-TRIM34. Lastly, Calyculin A inhibits protein phosphatases 1 and 2A, which results in an overall increase in the phosphorylation state of cellular proteins, some of which may be involved in enhancing the ligase activity of TRIM6-TRIM34.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that acts similarly to cAMP. It activates PKA, which can then phosphorylate substrates that may interact with TRIM6-TRIM34, thus enhancing its ligase activity for subsequent protein ubiquitination processes. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts as an agonist for beta-adrenergic receptors, which can lead to an increase in intracellular cAMP levels. This elevation in cAMP may activate PKA, which potentially phosphorylates proteins that interact with TRIM6-TRIM34, promoting its activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its receptors, leading to an increase in intracellular cAMP. The resultant PKA activation may lead to phosphorylation of proteins that associate with TRIM6-TRIM34, thus stimulating its ubiquitination activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP, leading to its accumulation. Higher cAMP levels can activate PKA, which may phosphorylate proteins and enhance the E3 ligase function of TRIM6-TRIM34. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits PDE4 and thereby prevents cAMP breakdown. The increased cAMP may activate PKA, which could phosphorylate proteins that interact with TRIM6-TRIM34, potentially promoting its ubiquitin ligase activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a protein synthesis inhibitor, which can lead to the activation of stress-activated protein kinases. These kinases could phosphorylate substrates that interact with TRIM6-TRIM34, potentially enhancing its enzymatic activity. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Salubrinal is a selective inhibitor of phosphatases that dephosphorylate eIF2α. Phosphorylated eIF2α can lead to the activation of stress response pathways, which may include the enhancement of TRIM6-TRIM34 ubiquitin ligase activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which can activate calcium-dependent kinases. These kinases might phosphorylate proteins that are involved in the activation of TRIM6-TRIM34's ligase function. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent kinases. These kinases might target proteins that interact with TRIM6-TRIM34, leading to its functional activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This could enhance the phosphorylation state of proteins that regulate the activity of TRIM6-TRIM34, thereby activating it. | ||||||